Pediatr. praxi. 2013;14(1):45-47

Neuroborreliosis versus sclerosis multiplex

MUDr.Peter Mikolášek1, MUDr.Lenka Krbková, CSc.1, MUDr.Lukáš Homola1, MUDr.Iva Čapovová1, MUDr.Tomáš Habanec, Ph.D.1, MUDr.Štefánia Rusnáková2, MUDr.Marie Daňková2, MUDr.Barbora Varadyová3, doc.MUDr.Jarmila Skotáková, CSc.4
1 Klinika dětských infekčních nemocí LF MU a FN Brno
2 Klinika dětské neurologie LF MU a FN Brno
3 Dětská oční klinika LF MU a FN Brno
4 Klinika dětské radiologie LF MU a FN Brno

Clinical symptoms in neuroborreliosis and multiple sclerosis can be similar at the begining of the disease. Basic laboratory values in both

diseases are quite non-specific, may be normal, or imitate a variety of other clinical entities. Therapeutic algorithm, severity of course

and particulary the possibility of permanent disability due to late diagnosis and treatment delay are quite different. Although there

are molecular mimicry hypotheses of lyme borreliosis as a potential trigger for multiple sclerosis (MS), there is not enough definitive

evidence for this opinion. The subject of this article is differential diagnosis, proper initiation and duration of therapy, including a case

report of a patient who fulfilled the clinical and laboratory criteria for both the MS and for neuroborreliosis.

Keywords: neuroborreliosis, multiple sclerosis, cerebrospinal fluid

Published: February 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mikolášek P, Krbková L, Homola L, Čapovová I, Habanec T, Rusnáková Š, et al.. Neuroborreliosis versus sclerosis multiplex. Pediatr. praxi. 2013;14(1):45-47.
Download citation

References

  1. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 2001; 2(22): 117-139. Go to original source... Go to PubMed...
  2. Victor M, Ropper A. Adams and Victor´s principles of neurology, 2001; 7th ed. Mc Graw-Hill, New York.
  3. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J. Neurol. Neurosurg. Psychiatr 1987; 5(50): 523-531. Go to original source... Go to PubMed...
  4. Gay D, Dick G. Spirochaetes, Lyme disease, and multiple sclerosis. Lancet 1986; 20: 685. Go to original source... Go to PubMed...
  5. Schmutzhard E, Pohl P, Stanek G. Borrelia burgdorferi antibodies in patients with relapsing/remitting form and chronic progressive form of multiple sclerosis. J. Neurol Neurosurg Psychiatr 1988; 51: 1215-1218. Go to original source... Go to PubMed...
  6. Coyle PK. Borrelia burgdorferi antibodies in multiple sclerosis patients. Neurology 1989; 39: 760-761. Go to original source... Go to PubMed...
  7. Demaerel P, Wilms G, Casteels K, et al. Chilhood neuroborreliosis: clinicordiological correlation. Neuroradiol 1995; 37: 578-581. Go to original source... Go to PubMed...
  8. Schmutzhard E. Entzündliche Erkrankungen des Nervensystem. Thieme 2000, Stuttgart. Go to original source...
  9. Coyle PK, Krupp LB, Doscher C. Significance of reactive Lyme serology in multiple sclerosis. Ann Neurol 1993; 34: 745-747. Go to original source... Go to PubMed...
  10. Reindl M, Linington C, Brehm U, et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 1999; 122: 2047-2056. Go to original source... Go to PubMed...
  11. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borreliosis. Neurol 1992; 42: 43-50. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.